# Gentherm Inc: Form 10-Q for the period ended Jun 30, 2018

- Company: [Gentherm Inc](/companies/thrm.md) (CIK 903129)
- Form: 10-Q
- Filed: 2018-07-31
- Accepted by EDGAR: Jul 31, 2018, 14:16 ET
- Period: 2018-06-30
- Accession: 0001564590-18-018059
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/903129/000156459018018059/thrm-10q_20180630.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/903129/000156459018018059/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2018-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Gross profit | 3 months, 2018-04-01 to 2018-06-30 | $74.5m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2018-01-01 to 2018-06-30 | $153.0m | us-gaap:GrossProfit |
| Research and development | 3 months, 2018-04-01 to 2018-06-30 | $21.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2018-01-01 to 2018-06-30 | $44.3m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2018-04-01 to 2018-06-30 | $31.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2018-01-01 to 2018-06-30 | $65.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2018-04-01 to 2018-06-30 | $15.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2018-01-01 to 2018-06-30 | $36.2m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2018-04-01 to 2018-06-30 | $3.1m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2018-01-01 to 2018-06-30 | $6.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2018-04-01 to 2018-06-30 | $16.7m | us-gaap:ProfitLoss |
| Net income | 6 months, 2018-01-01 to 2018-06-30 | $29.6m | us-gaap:ProfitLoss |
| Diluted EPS | 3 months, 2018-04-01 to 2018-06-30 | $0.45 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2018-01-01 to 2018-06-30 | $0.81 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2018-04-01 to 2018-06-30 | $0.46 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2018-01-01 to 2018-06-30 | $0.81 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2018-04-01 to 2018-06-30 | 36,666,999 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2018-01-01 to 2018-06-30 | 36,663,226 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2018-01-01 to 2018-06-30 | $32.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2018-01-01 to 2018-06-30 | $22.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 6 months, 2018-01-01 to 2018-06-30 | $20.2m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2018-06-30 | $65.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2018-06-30 | $446.6m | us-gaap:AssetsCurrent |
| Total assets | at 2018-06-30 | $890.0m | us-gaap:Assets |
| Current liabilities | at 2018-06-30 | $171.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2018-06-30 | $301.6m | us-gaap:Liabilities |
| Long-term debt | at 2018-06-30 | $109.5m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2018-06-30 | $3.4m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2018-06-30 | $588.4m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 38,678 characters.

### Forward-Looking Statements

*This Report contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements represent our goals, beliefs, plans and expectations about our prospects for the future and other future events, such as our ability to execute our new strategic plan, our ability to finance sufficient working capital, the amount of availability under our credit agreement and other indebtedness, our ability to continue to maintain or increase sales and profits of our operations, and the sufficiency of our cash balances and cash generated from operating, investing and financing activities for our future liquidity and capital resource needs. Reference is made in particular to forward-looking statements included in this “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and Note 1 to the consolidated condensed financial statements. Such statements may be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “believe”, “estimate”, “anticipate”, “intend”, “continue”, or similar terms, variations of such terms or the negative of such terms. The forward-looking statements included in this Report are made as of the date hereof or as of the date specified and are based on management’s current expectations and beliefs. Such statements are subject to a number of assumptions, risks, uncertainties and other factors, which are set forth in “Item 1A. Risk Factors” and elsewhere in our Annual Report on Form 10-K for the year ended December 31, 2017, and subsequent reports filed with or furnished to the Securities and Exchange Commission, and which could cause actual results to differ materially from that described in the forward-looking statements. Except as required by law, we expressly disclaim any obligation or undertaking to update any forward-looking statements to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.*

The following discussion and analysis should be read in conjunction with, and is qualified in its entirety by, our consolidated financial statements and related notes thereto included elsewhere in this Report and in our Annual Report on Form 10-K for the year ended December 31, 2017.

### Overview

Gentherm Incorporated is a global technology and industry leader in the design, development, and manufacturing of innovative thermal management technologies. Our products provide solutions for automotive passenger comfort and convenience, battery thermal management, remote power generation, patient temperature management, environmental product testing and other consumer and industrial temperature control needs. Our automotive products can be found on the vehicles of nearly all major automotive manufacturers operating in North America, Europe and Asia. We operate in locations aligned with our major customers’ product strategies in order to provide locally enhanced design, integration and production capabilities and to identify future thermal technology product opportunities in both automotive and other markets. We concentrate our research on the development of new technologies and new applications from existing technologies to create product and market opportunities for a wide array of thermal management solutions.

Our automotive products are sold to automobile and light truck OEMs or their tier one suppliers. Inherent to the automotive supplier market are costs and commitments that are incurred well in advance of the receipt of orders and resulting revenues from customers. This is due in part to automotive manufacturers requiring the design, coordination and testing of proposed new components and sub-systems. Revenues from these expenditures are typically not realized for two to three years due to this development cycle.

The Company has two reportable segments for financial reporting purposes: Automotive and Industrial. See Note 5 to our consolidated condensed financial statements for a description of our reportable segments as well as their proportional contribution to the Company’s reported product revenues and operating income. The financial information used by our chief operating decision maker to assess operating performance and allocate resources is based on these reportable segments.

#### Etratech

On November 1, 2017, we acquired substantially all of the assets and assumed substantially all of the operating liabilities of Etratech Inc. (“Etratech”), an Ontario corporation and all of the outstanding shares of Etratech Hong Kong, an entity organized under the laws of Hong Kong, in an all-cash transaction. Etratech manufactures advanced electronic controls and control systems for the automotive, RV and marine, security, medical and other industries. Etratech’s world headquarters and North American manufacturing operations are located in Burlington, Canada. See Note 3 to the consolidated condensed financial statements for additional information regarding the acquisition of Etratech.

### New Strategic Plan

On June 25, 2018, Gentherm announced a new strategic plan intended to improve business performance and position the company to deliver above-market growth and improved profitability to its shareholders. An important element of the strategy is the Fit-for-Growth initiative that focuses on purchasing excellence, rationalization of research and development activities and expenses, reducing selling, general and administrative expense, minimization or elimination of investments in non-core areas and developing a manufacturing footprint commensurate with the new plan. Non-core areas of investment so far identified under the Fit-for-Growth initiative are concentrated in the following areas of Gentherm’s industrial segment: California Advanced Research and Development, Gentherm Global Power Technologies (GPT) and Cincinnati Sub Zero’s Industrial Chamber business (CSZ-IC).

The strategy also identified several product categories the Company will exit, including furniture, aviation, battery management electronics, industrial battery packs, automotive thermoelectric generators and other non-core electronics.

See Note 1 to our consolidated condensed financial statements for information about our Fit-for-Growth initiative, related cost savings and related restructuring costs.

### Critical Accounting Policies

The discussion and analysis of our financial condition and results of operations are based upon our consolidated condensed financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. See Note 2 to our consolidated condensed financial statements for information about critical accounting policies, accounting standard updates adopted during the six-month period ended June 30, 2018 and their impact on the Company’s consolidated financial statements, and recently issued accounting policies not yet adopted.

### Results of Operations Second Quarter 2018 Compared with Second Quarter 2017

*Product Revenues*. Product revenues for the three-month period ended June 30, 2018 (“Second Quarter 2018”) were $263.8 million compared with product revenues of $243.4 million for the three-month period ended June 30, 2017 (“Second Quarter 2017”), an increase of $20.4 million, or 8%. Higher product revenues in the automotive segment, which increased by $25.0 million, or 12%, to $240.8 million, were partially offset by lower industrial segment product revenues which decreased by $4.6 million, or 17%, to $23.0 million. The higher automotive segment sales included $15.2 million related to Etratech and a favorable effect from currency translation of $6.5 million. Etratech was acquired on November 1, 2017 and therefore no product revenue was reported for Etratech during Second Quarter 2017. On a pro-forma basis, Etratech revenue increased more than 7%.

Without the benefit of the currency translation and adjusting for the Etratech acquisition, automotive segment product revenue would have increased by 2%. This increase occurred despite lower automotive production volumes in North America, our most important geographic market. These increases were partially offset by annual price reductions totaling $6.5 million and from a lower average selling price of climate controlled seats (“CCS”) resulting from certain vehicle programs changing technologies from the higher priced active cooling application to heated and ventilated seating technology. In North America, which represented approximately 47% of our automotive revenue during Second Quarter 2018, automotive production decreased by 2.5% during Second Quarter 2018. Lower production significantly impacted two important customers in Second Quarter 2018. Automotive production at Ford, representing 11% of our product revenues, was down more than 13% in North America and production for Hyundai, representing 8% of our product revenues, was down by 5% in Korea and down 10% in North America. These lower production volumes disproportionately impacted our CCS products more than our other products. All of our other automotive products had higher revenue despite the weak production volumes. Battery Thermal Management products (“BTM”), which includes the actively cooled version launched this year, grew by $4.6 million, or 170%, to $7.2 million due to the launch of the second vehicle program with actively cooled BTM on the Jeep Wrangler in addition to the first ever actively cooled BTM launched on the Mercedes S-Class during the 2018 first quarter. Other programs showing significant growth included Steering Wheel Heaters which increased by $3.0 million, or 21% to $17.5 million, automotive cable systems which grew by $3.7 million, or 17%, to $25.6 million and automotive seat heaters which grew by $6.4 million, or 9%, to $80.2 million. On a combined basis all automotive product revenue, adjusting for currency translation and the Etratech acquisition and excluding CCS, grew by nearly 10%.

Product revenues from Gentherm Global Power Technologies (“GPT”), included in the industrial segment, totaled $5.2 million which represented a decrease of $2.3 million, or 31%. This decrease was mainly due to significantly lower custom project revenue. Custom projects, which typically represent more than 50% of GPT’s product revenue, tend to vary significantly period-to-period due to timing of the relatively large per unit revenue. Revenue for Cincinnati Sub-Zero Products, LLC (“CSZ”) during Second Quarter 2018 was $17.8 million, representing a decrease of $2.3 million, or 11%. This decrease was mainly due to lower product revenue on climate testing chambers offset partially by higher product revenues of medical products. The climate chamber product revenue decrease of $2.7 million, or 20%, was primarily due to unusually high product revenues during Second Quarter 2017 which benefited from the shipment of several large custom projects. CSZ’s medical product revenues increased by $386 thousand, or 5%, during the Second Quarter 2018.

*Cost of Sales.* Cost of sales increased to $189.3 million during Second Quarter 2018 from $165.1 million during Second Quarter 2017. This increase of $24.2 million, or 15%, was due to the higher product revenue and a lower gross margin percentage. The gross margin percentage during Second Quarter 2018 decreased to 28.2% from 32.2% during Second Quarter 2017 primarily due to changes in product mix, timing differences between annual customer price decreases compared to supplier cost reductions, lower margin on BTM associated with the launch phase of the new actively cooled technology programs and the lower margin of Etratech, partially offset by fixed cost leverage from higher unit volume. An unfavorable shift in product mix largely was due to lower sales for higher margin products including CCS and GPT. Annual price reductions start in the first quarter and are expected to be offset by lower supplier and other costs as those programs begin to take effect throughout the year. The new actively cooled battery thermal management product being launched in our Macedonia facility is anticipated to generate annual revenue in the range of $50 to $60 million but is still in the early phase with only $4.5 million in product revenues during the Second Quarter 2018. Lower gross margin on this product during this period is due to launch related expenses and higher fixed overhead costs, including depreciation expense, being incurred in anticipation for the much higher expected volumes. We expect that higher revenues of BTM units will offset these expenses in future periods.

On July 6, 2018, tariffs announced by the Office of the United States Trade Representative (USTR) under the Section 301 Action went into effect. All items identified as classified under the Harmonized Tariff Schedule of the United States (HTSUS) with a country of origin of China are subject to a 25% duty upon importation into the United States. Gentherm purchases raw material components, including products manufactured in our China facilities, that are subject to the tariff. As a result, we estimate higher raw material expenses ranging from $3 to $5 million during the second half of 2018. This estimate includes the 25% duty effecting identified items under HTSUS, plus an additional 10% duty on a second statement of goods that has been proposed but has not gone into effect. We are working with our suppliers and customers to mitigate the impact from these tariffs to the Company’s operating results.

*Net Research and Development Expenses.* Net research and development expenses were $21.0 million during Second Quarter 2018 compared to $21.4 million in Second Quarter 2017, a decrease of $385 thousand, or 2%. Higher research and development reimbursements totaling $3.0 million was partially offset by higher research and development expenses. These increased expenses were primarily driven by higher costs for additional resources, including personnel, focused on application engineering for new production programs of existing products, development of new products and a program to develop the next generation of seat comfort products. The increase also included approximately $712 thousand in foreign currency translation and the net research and development expenses of Etratech totaling $630 thousand. New product development included automotive cooled storage devices, automotive interior thermal management devices, medical thermal management devices, battery thermal management devices, battery management systems, advanced automotive electronics solutions and other potential products. We expect that the new strategy announced on June 25, 2018 will result in a decrease in research and development expenses and a reallocation of certain resources to products that meet the requirements of the new focused growth strategy.

Research and development reimbursement totaled $4.6 million during Second Quarter 2018 and $1.6 million during Second Quarter 2017. This increase was mainly attributable to development expense reimbursements paid by customers for products launched during the period and the addition of Etratech.

*Selling, General and Administrative Expenses.* Selling, general and administrative expenses were $31.6 million during Second Quarter 2018, a decrease of $134 thousand from $31.8 million during Second Quarter 2017. Increases in selling, general and administrative expenses associated with the acquisition of Etratech totaling $1.3 million, mark-to-market adjustments on cash settled stock options totaling $889 thousand and foreign currency translation totaling $392 thousand, were more than offset by lower expenses associated with the early cost reduction activities of the Company’s new strategic initiatives.

*Foreign currency gain (loss).* During Second Quarter 2018 we incurred a net foreign currency gain of $5.2 million which included a net realized gain of $632 thousand and a net unrealized gain of $4.5 million. The unrealized gain is primarily the result of holding significant amounts of U.S. Dollar (“USD”) cash at our subsidiaries in Europe which have the European Euro (“EUR”) as the functional currency and due to certain intercompany relationships between these European subsidiaries and our U.S. based companies. During Second Quarter 2018, the USD strengthened relative to the EUR. If the USD begins weakening, we will likely have unrealized currency losses whereas if the USD continues to strengthen we will likely have additional unrealized gains. Second Quarter 2017, we had a foreign currency loss of $13.3 million. In comparison to Second Quarter 2017, the foreign currency impact in Second Quarter 2018 was lower due to a smaller change in currency exchange rates during Second Quarter 2018 as compared to Second Quarter 2017.

*Income Tax Expense.* We recorded an income tax expense of $3.1 million during Second Quarter 2018 representing an effective tax rate of 16% on earnings before income tax of $19.7 million. During Second Quarter 2017, we recorded an income tax expense of $2.4 million on earnings before tax of $10.9 million, or 22%. The effective tax rate for Second Quarter 2018 differed from the Federal statutory rate of 21% primarily due to the impact of discrete adjustments, including favorable excess tax benefits on stock option exercises and certain intercompany transactions which disproportionately benefited lower tax rate jurisdictions which were partially offset by the international provisions from the U.S. tax reform, such as global intangible low-tax income (“GILTI”), enacted in December 2017. The effective tax rate for Second Quarter 2017 was lower than the U.S. Federal rate of 34% primarily due to the impact of lower statutory rates for our subsidiaries operating in foreign jurisdictions.

*Industrial Segment Operating Loss.* The Industrial segment, which includes CSZ, GPT and our advanced research and development activities, reported an operating loss totaling $7.9 million and $2.7 million during Second Quarter 2018 and Second Quarter 2017, respectively. We incurred these losses for several reasons. First, the advanced research and development activities, the total cost for which were $3.1 million and $3.3 million, during Second Quarter 2018 and Second Quarter 2017, respectively, are focused on products and technologies that are currently not generating product revenues. Second, in conjunction with the Fit-for-Growth initiative, some of these advanced research and development activities have been curtailed or ceased and a process has been started to consolidate our advanced research facilities into few locations. These changes are expected to lead to lower spending rates in future periods. Because of this, the industrial segment operating loss included a portion of the restructuring charge totaling $3.7 million. We expect that the remaining advanced technology projects will generate profitable revenue in future periods. Next, CSZ’s $1.2 million of expenses associated with a new direct sales force is not yet fully offset by a corresponding increase in the amount of revenue and related operating income. We continue to believe that the direct sales force will lead to higher CSZ product revenue in future periods that will generate operating profits in excess of the costs for the direct sales team.

### Results of Operations First Half 2018 Compared with First Half 2017

*Product Revenues*. Product revenues for the six-month period ended June 30, 2018 (“First Half 2018”) were $525.7 million compared with product revenues of $492.6 million for the six-month period ended June 30, 2017 (“First Half 2017”), an increase of $33.0 million, or 7%. Higher product revenues in the automotive segment which increased by $44.2 million, or 10%, to $481.8 million were partially offset by lower industrial segment product revenues which decreased by $10.2 million, or 19%, to $44.8 million. The higher automotive segment sales included $30.4 million related to the acquisition of Etratech and a favorable effect from currency translation of $17.0 million. Etratech was acquired on November 1, 2017 and therefore no product revenue was reported for Etratech during First Half 2017. On a pro-forma basis, Etratech revenue increased by 13%.

Without the benefit of the currency translation and adjusting for the Etratech acquisition, automotive segment product revenue would have been unchanged during First Half 2018 as compared to First Half 2017. Growth measured on this basis during Second Quarter 2018 was fully offset by decreased revenue in the 2018 first quarter.

Product revenues from GPT, included in the industrial segment, totaled $9.73 million which represented a decrease of $5.2 million, or 35%. This decrease was mainly due to significantly lower custom project revenue. Custom projects, which typically represent more than 50% of GPT’s product revenue, tend to vary significantly period-to-period due to timing of the relatively large per unit revenue. Revenue for CSZ during First Half 2018 was $35.1 million, representing a decrease of $5.0 million, or 12.5%. This decrease was mainly due to lower climate chamber product revenue which decreased by $2.7 million, or 12%, to $20.5 million as a result of unusually high product revenues during First Half 2017 which benefited from the shipment of several large customer projects. CSZ’s medical sales also declined by $2.3 million, or 13%, to $14.6 million mainly due to a $2.6 million decline in sales of the blood heater-cooler product that was higher during First Half 2017 due to the regulatory disruptions impacting a competitive product.

*Cost of Sales.* Cost of sales increased to $372.7 million during First Half 2018 from $329.2 million during First Half 2017. This increase of $43.5 million, or 13%, was due to the higher product revenue and a lower gross margin percentage. The gross margin percentage during First Half 2018 decreased to 29.1% from 33.2% during First Half 2017 mainly as a result of timing differences between annual customer price decreases compared to supplier cost reductions, increased manufacturing expenses, changes in product mix favoring lower margin products and lower margin on BTM associated with the launch phase of the new actively cooled technology programs and the lower margin of Etratech, partially offset by fixed cost leverage from higher unit volume. Annual price reductions start in the first quarter and are expected to be offset by lower supplier and other costs as those programs begin to take effect throughout the year. Increased expenses included labor expense inflation at our Ukraine factory, and factory launch expenses for the new advanced battery thermal management product in our Macedonia facility. An unfavorable shift in product mix largely was due to lower sales for higher margin products including CCS, GPT and the medical products of CSZ.

*Net Research and Development Expenses.* Net research and development expenses were $44.3 million during First Half 2018 compared to $40.9 million in First Half 2017, an increase of $3.4 million, or 8%. This increase was primarily driven by higher costs for additional resources, including personnel, focused on application engineering for new production programs of existing products, development of new products and a program to develop the next generation of seat comfort products. The increase also included approximately $1.5 million in foreign currency translation and the net research and development expenses of Etratech totaling $1.3 million. These amounts were partially offset by $3.1 million in higher research and development reimbursements.

Research and development reimbursement totaled $7.0 million during First Half 2018 and $3.8 million during First Half 2017. This increase was mainly attributable to development expense reimbursements paid by customers for products launched during the period and the addition of Etratech.

*Selling, General and Administrative Expenses.* Selling, general and administrative expenses increased to $65.4 million during First Half 2018, an increase of $2.8 million, or 4%, from $62.6 million during First Half 2017. This increase includes approximately $1.4 million in higher expenses related to currency translation and $3.2 million in selling, general and administrative expenses of Etratech. These increases were partially offset by lower mark-to-market adjustments on cash settled stock options totaling $706 thousand and by lower expenses associated with the early cost reduction activities of the Company’s new strategic initiatives.

*Foreign currency gain (loss).* During First Half 2018, we incurred a net foreign currency gain of $600 thousand which included a net realized loss of $294 thousand and a net unrealized gain of $890 thousand. The unrealized gain is primarily the result of holding significant amounts of USD cash at our subsidiaries in Europe which have EUR as the functional currency and due to certain intercompany relationships between these European subsidiaries and our U.S. based companies. During First Half 2018, the USD strengthened relative to the EUR. If the USD begins to weaken we will likely have unrealized currency losses whereas if the USD continues to strengthen we will likely have additional unrealized gains. In First Half 2017, we had a net foreign currency loss of $14.6 million. In comparison to First Half 2017, the foreign currency impact in First Half 2018 was lower due to a smaller change in currency exchange rates during First Half 2018 as compared to First Half 2017.

*Income Tax Expense.* We recorded an income tax expense of $6.1 million during First Half 2018 representing an effective tax rate of 17% on earnings before income tax of $35.7 million. During First Half 2017, we recorded an income tax expense of $9.6 million on earnings before tax of $43.5 million, or 22%. The effective tax rate for First Half 2018 differed from the Federal statutory rate of 21% primarily due to the impact of discrete adjustments, including a favorable excess tax benefit on stock option exercises, certain intercompany transactions which disproportionately benefited lower tax rate jurisdictions and the impact of lower statutory rates for our subsidiaries operating in foreign jurisdictions offset by the international provisions from the U.S. tax reform, such as GILTI, enacted in December 2017. The effective tax rate for First Half 2017 was lower than the U.S. Federal rate of 34% primarily due to the impact of lower statutory rates for our subsidiaries operating in foreign jurisdictions.

*Industrial Segment Operating Loss.* The Industrial segment, which includes CSZ, GPT and our advanced research and development activities, reported an operating loss totaling $14.6 million and $5.1 million during First Half 2018 and First Half 2017, respectively. We incurred these losses for several reasons. First, the advanced research and development activities, the total cost for which were $6.9 million and $7.3 million, during First Half 2018 and First Half 2017, respectively, are focused on products and technologies that are currently not generating product revenues. Second, in conjunction with the Fit-for-Growth initiative, some of these activities have been curtailed or ceased and a process has been started to consolidate our advanced research facilities into few locations. These changes are expected to lead to lower spending rates in future periods. Because of this, the industrial segment operating loss included a portion of the restructuring charge totaling $3.8 million. We expect that the remaining advanced technology projects will generate profitable revenue in future periods. Next, CSZ’s $2.4 million of expenses associated with a new direct sales force is not yet fully offset by a corresponding increase in the amount of revenue and related operating income. We continue to believe that the direct sales force will lead to higher CSZ product revenue in future periods that will generate operating profits in excess of the costs for the direct sales team.

### Liquidity and Capital Resources

### Cash and Cash Flows

The Company has funded its financial needs primarily through cash flows from operating activities and equity and debt financings. Our new strategic plan sets fourth a capital allocation strategy that includes a targeted debt to earnings leverage ratio and allows for some of our cash flow to be paid back to investors though common stock buybacks. On June 25, 2018 our board increased the Company’s stock buyback authorization to $300 million under which we had $274 remaining as of June 30, 2018. This authorization expires on December 31, 2020. Based on its current operating plan, management believes cash and cash equivalents at June 30, 2018, together with cash flows from operating activities, and borrowing available under our credit agreement, are sufficient to meet operating and capital expenditure needs, and to service debt, for at least the next 12 months. However, if cash flows from operations decline, we may need to obtain alternative sources of capital and reduce or delay capital expenditures, acquisitions and investments, all of which could impede the implementation of our business strategy and adversely affect our results of operations and financial condition. In addition, it is likely that we will need to complete one or more equity or debt financings if we consummate any significant acquisition or a number of smaller acquisitions. There can be no assurance that such capital will be available at all or on reasonable terms, which could adversely affect our future operations and business strategy.

The following table represents our cash and cash equivalents and short-term investments:

*(In thousands)*

|  | Six Months Ended June 30, 2018 | Year Ended December 31, 2017 |
| --- | ---: | ---: |
| Cash and cash equivalents at beginning of period | $103,172 | $177,187 |
| Cash from operating activities | 32,543 | 49,880 |
| Cash used in investing activities | (21,455) | (117,688) |
| Cash used in financing activities | (47,899) | (31,564) |
| Foreign currency effect on cash and cash equivalents | (1,004) | 25,357 |
| Cash and cash equivalents at end of period | $65,357 | $103,172 |

#### Cash Flows From Operating Activities

We manage our cash, cash equivalents and short-term investments in order to fund operating requirements and preserve liquidity to take advantage of future business opportunities. The following table compares the cash flows from operating activities during First Half 2018 and First Half 2017:

*(In thousands)*

| Operating Activities: | Six Months Ended June 30, 2018 | 2017 | Change |
| --- | ---: | ---: | ---: |
| Net income | $29,625 | $33,915 | $(4,290) |
| Non-cash adjustments to reconcile net income to cash provided by operating activities: |  |  |  |
| Depreciation and amortization | 25,823 | 21,191 | 4,632 |
| Deferred income taxes | (1,799) | (2,278) | 479 |
| Stock compensation | 4,063 | 4,761 | (698) |
| Defined benefit plan expense | (103) | 94 | (197) |
| Provision for doubtful accounts | 204 | 6 | 198 |
| Loss on sale of property and equipment | 2,156 | 249 | 1,907 |
| Net income before changes in operating assets and liabilities | 59,969 | 57,938 | 2,031 |
| Changes in operating assets and liabilities: |  |  |  |
| Accounts receivable | (17,469) | (6,949) | (10,520) |
| Inventory | 1,631 | 1,149 | 482 |
| Prepaid expenses and other assets | (12,094) | (5,147) | (6,947) |
| Accounts payable | 10,540 | (2,932) | 13,472 |
| Accrued liabilities | (10,034) | (37,944) | 27,910 |
| Net cash provided by operating activities | 32,543 | 6,115 | 26,428 |

31

Cash provided by operating activities during First Half 2018 was $32.5 million, representing an increase of $26.4 million from cash provided in operating activities during First Half 2017, which was $6.1 million. The following table highlights significant differences between the operating cash flows for the periods ending June 30, 2018 and 2017, respectively:

*(In thousands)*

|  |  |
| --- | ---: |
| Net cash provided by operating activities during First Half 2017 | $6,115 |
| Increase from higher net income before changes in operating assets and liabilities | 2,031 |
| Taxes paid related to the Reorganization (as defined below) | 35,100 |
| Other changes in working capital, net. | (10,703) |
| Net cash provided by operating activities during First Half 2018 | $32,543 |

Net cash provided by operating activities before changes in operating assets and liabilities increased during First Half 2018 due to higher revenue offset partially by higher expenses.

In addition, operating cash flows were lower due to income tax payments related to reorganization transactions of our North American business operations (the “Reorganization”). As part of our original integration plan to eliminate redundancies associated with the 2011 acquisition of Gentherm GmbH (formerly named W.E.T. Automotive Systems AG), the Windsor Operations were consolidated into our existing European and North American facilities.

Related to these reorganization transactions, the Company declared intercompany dividends, incurred and paid withholding taxes to the Canadian Revenue Agency of $7.6 million during 2016. Additionally, the Company incurred income tax expense of $2.5 million related to the intercompany dividends. These amounts incurred are expected to cover all future intercompany dividends needed to distribute the remaining earnings of the subsidiary to its parent in conjunction with the potential future liquidation of the subsidiary.

In addition to the $7.6 million of withholding tax and $2.5 million of income taxes, the Company was required to make a one-time income tax payment of approximately $32.6 million. The one-time income tax payment was accrued during the first quarter of 2016; however, the Company also recorded an offsetting deferred charge for approximately the same amount because the one-time income tax payment will result in tax deductions against income taxes in future periods. Therefore, the income tax payment did not have a material impact on the Company’s earnings during the first quarter of 2016 nor any subsequent quarter. The withholding tax payment was paid entirely in 2016. The income tax payments of $2.5 million and $32.6 million were paid during the first quarter of 2017.

Other changes in working capital, net primarily consist of favorable cash flows related to accounts receivable, prepaid expenses and other assets and unfavorable amounts related to inventory and accounts payable.

#### Working Capital

The following table illustrates changes in working capital during First Half 2018:

*(In thousands)*

|  |  |
| --- | ---: |
| Working capital at December 31, 2017 | $289,754 |
| Loan repayments | (46,742) |
| U.S. Revolving Note borrowings | 15,000 |
| Stock buyback | (20,241) |
| Foreign currency effect on working capital | (4,449) |
| Increase in accounts receivable | 17,469 |
| Increase in tax receivables | 10,240 |
| Increase in accounts payable | (10,540) |
| Adoption of ASU 2016-16 | 22,585 |
| Adoption of ASU 2014-09 | (4,105) |
| Other Items | 5,911 |
| Working capital at June 30, 2018 | $274,882 |

32

Our working capital decreased due to a net repayment of a portion of the Company’s outstanding debt balance, cash paid to the buy back Common Stock and a decrease in accounts payable, partially offset by three significant increases, including currency translation, an increase in accounts receivable and tax receivable, and non-cash adjustments from the adoption of new accounting standard updates. During First Half 2018, management repaid $45.0 million of the outstanding U.S. Revolving Note balance, $1.2 million of the outstanding DEG Vietnam Loan and $0.5 million of the outstanding DEG China Loan from cash from operations and cash repatriated from foreign subsidiaries. The currency impact of $2.8 million on working capital is mainly the result of the currency translation of working capital at our European subsidiaries. At June 30, 2018, the U.S. Dollar/European Euro exchange rate was $1.17 as compared with an exchange rate of $1.23 at December 31, 2017. Approximately 20% of our product revenues are generated in Europe. Working capital was also impacted by an increase in account receivable, which was driven by higher sales in June 2018 as compared to December 2017. Our sales are typically lower in December each year due to temporary factory holiday shut-downs at our automotive customers. During First Half 2018, Gentherm recognized an increase to current tax receivables related to timing of required payments to tax authorities. Lastly, working capital was impacted by the adoption of Accounting Standard Update 2016-16, “Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory” and Accounting Standard Update 2014-09, “Revenue from Contracts with Customers (Topic 606).” See Note 2 to our consolidated condensed financial statements for information about these accounting standard updates and their impact on the Company’s consolidated condensed financial statements.

#### Cash Flows From Investing Activities

Cash used in investing activities was $21.5 million during First Half 2018, reflecting purchases of property and equipment related to the expansion of production capacity, including at our newest facilities in Mexico, Vietnam, Macedonia and our Etratech facility in Canada.

#### Cash Flows From Financing Activities

Cash used in financing activities was $47.9 million during First Half 2018, reflecting payments of principal on the U.S. Revolving Note, the DEG China Loan and the DEG Vietnam Loan totaling $46.7 million in aggregate. As of June 30, 2018, the total availability under the U.S. Revolving Note was $250.9 million. Cash was also paid for cancellations of restricted stock awards totaling $882 thousand, and for the repurchase of Common Stock totaling $20.2 million.

#### Off-Balance Sheet Arrangements

We use letters of credit to guarantee our performance under specific construction contracts executed by our subsidiaries, GPT and CSZ. The expiration dates of the letter of credit contracts coincide with the expected completion date of the contract. Extensions are normally made if performance obligations continue beyond the expected completion date. At June 30, 2018, we had outstanding letters of credit of $66 thousand, a decrease from $141 thousand at December 31, 2017.

## Market risk

As filed, 5,794 characters.

Our exposure to market risk for changes in interest rates relates primarily to our debt obligations and foreign currency contracts. We have in the past, and may in the future, place our investments in bank certificates of deposits, debt instruments of the U.S. government, and in high-quality corporate issuers.

We are exposed to market risk from changes in foreign currency exchange rates, short-term interest rates and price fluctuations of certain material commodities such as copper. Market risks for changes in interest rates relate primarily to our debt obligations under our Credit Agreement. Foreign currency exchange risks are attributable to sales to foreign customers and purchases from foreign suppliers not denominated in a location’s functional currency, foreign plant operations, intercompany indebtedness, intercompany investments and include exposures to the European Euro, Mexican Peso, Canadian Dollar, Hungarian Forint, Macedonian Denar, Ukrainian Hryvnia, Japanese Yen, Chinese Renminbi, Korean Won and Vietnamese Dong.

The Company regularly enters into derivative contracts with the objective of managing its financial and operational exposure arising from these risks by offsetting gains and losses on the underlying exposures with gains and losses on the financial instruments used to hedge them. The maximum length of time over which we hedge our exposure to foreign currency exchange risks is one year. We had foreign currency derivative contracts with a notional value of $22.4 million and $29.3 million outstanding at June 30, 2018 and December 31, 2017, respectively.

The maximum length of time over which we hedge our exposure to price fluctuations in material commodities is two years. We had copper commodity swap contracts with a notional value of $0 and $404 thousand outstanding at June 30, 2018 and December 31, 2017, respectively.

We do not enter into derivative financial instruments for speculative or trading purposes. Our hedging relationships are formally documented at the inception of the hedge, and hedges must be highly effective in offsetting changes to future cash flows on hedged transactions both at the inception of a hedge and on an ongoing basis to be designated for hedge accounting treatment. For derivative contracts which can be classified as a cash flow hedge, the effective portion of the change in the fair value of the derivative is recorded to accumulated other comprehensive income (loss) in the consolidated condensed balance sheet. When the underlying hedge transaction is realized, the gain or loss included in accumulated other comprehensive income (loss) is recorded in earnings in the consolidated condensed statements of income on the same line as the gain or loss on the hedged item attributable to the hedged risk. We record the ineffective portion of foreign currency hedging instruments, if any, to foreign currency gain (loss) in the consolidated condensed statements of income. Though we continuously monitor the hedging program, derivative positions and hedging strategies, foreign currency forward exchange agreements have not always been designated as hedging instruments for accounting purposes.

The Company uses an income approach to value derivative instruments, analyzing quoted market prices to calculate the forward values and then discounts such forward values to the present value using benchmark rates at commonly quoted intervals for the instrument’s full term. Information related to the fair values of all derivative instruments in our consolidated condensed balance sheet as of June 30, 2018 is set forth in Note 7 to the consolidated condensed financial statements included herein.

#### Interest Rate Sensitivity

The table presents principal cash flows and related weighted average interest rates by expected maturity dates for each of the Company’s debt obligations. The information is presented in U.S. dollar equivalents, which is the Company’s reporting currency. The instruments actual cash flows are denominated in US dollars ($USD) or European Euros (€EUR), as indicated in parentheses.

### June 30, 2018

*(In thousands except rate information)*

| Liabilities Long Term Debt: | Expected Maturity Date 2018 | 2019 | 2020 | 2021 | 2022 | Thereafter | Total | Fair Value |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Fixed Rate (€EUR) | $467 | $933 | — | — | — | — | $1,400 | $1,400 |
| Fixed Interest Rate | 4.25% | 4.25% |  |  |  |  | 4.25% |  |
| Variable Rate ($USD) | — | — | — | — | $99,000 | — | $99,000 | $99,000 |
| Average Interest Rate |  |  |  |  | 3.59% |  | 3.59% |  |
| Fixed Rate ($USD) | $1,250 | $2,500 | $2,500 | $2,500 | $2,500 | $1,250 | $12,500 | $12,200 |
| Fixed Interest Rate | 5.21% | 5.21% | 5.21% | 5.21% | 5.21% | 5.21% | 5.21% |  |

34

#### Exchange Rate Sensitivity

The table below provides information about the Company’s foreign currency forward exchange rate agreements that are sensitive to changes in foreign currency exchange rates. The table presents the notional amounts and weighted average exchange rates by expected (contractual) maturity dates for each type of foreign currency forward exchange agreement. These notional amounts generally are used to calculate the contractual payments to be exchanged under the contract.

### June 30, 2018

*(In thousands except rate information)*

| Anticipated Transactions And Related Derivatives $US functional currency Forward Exchange Agreements: (Receive MXN/Pay USD$) | Expected Maturity or Transaction Date 2018 | 2019 | 2020 | 2021 | 2022 | Thereafter | Total | Fair Value |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total Contract Amount | $18,322 | $4,075 | — | — | — | — | $22,397 | $(454) |
| Average Contract Rate | 19.65 | 19.63 |  |  |  |  | 19.65 |  |

## Controls and procedures

As filed, 1,345 characters.

### (a) Evaluation of Disclosure Controls and Procedures

As of the end of the period covered by this quarterly report, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of June 30, 2018, our disclosure controls and procedures were effective to ensure the information required to be disclosed by us in reports that we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized, and reported within the time periods prescribed by the Securities and Exchange Commission, and that such information is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

### (b) Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during the quarter ended June 30, 2018 that have materially affected, or are reasonably likely to materially effect, our internal control over financial reporting.

## Risk factors

As filed, 1,291 characters.

*Rising threats of international tariffs, including tariffs applied to goods traded between the United States and China, could materially and adversely affect our business and results of operations.*

Since the beginning of 2018, there has been increasing rhetoric, in some cases coupled with legislative or executive action, from several U.S. and foreign leaders regarding the possibility of instituting additional tariffs against foreign imports of certain materials and products. In March and April of 2018, the U.S. and China have applied tariffs to certain of each other’s exports. The institution of trade tariffs both globally and between the U.S. and China specifically carries the risk of negatively impacting overall economic conditions, which could have negative repercussions on the Company. Furthermore, imposition of tariffs has caused and could cause further increases in the costs of our raw materials, which we may not be able to pass on to our customers, which would directly and negatively impact our business.

There were no other material changes in our risk factors previously disclosed in Part I, Item 1A “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2017. You should carefully consider the risks and uncertainties described therein.

Filed Jul 31, 2018.
Source: SEC EDGAR, the filing index for accession 0001564590-18-018059. Last ingested by Listed: Oct 26, 2026, 17:44 ET. No prices; not investment advice.
